Johnson & Johnson increased net profit by 42% in the second quarter


American manufacturer of health products Johnson & Johnson, following the results of the second quarter, reported a net profit growth 1.4 times compared with the same period a year earlier to $5.607 billion. Adjusted earnings, which do not take into account one-time factors, increased by 23% over the year to $2.58 per share and exceeded economists’ forecast of $2.46 per share. Revenues amounted to 20.56 billion dollars, a decrease of 1.3% over the past 12 months. In organic terms, the index increased by 3.9%. During the earnings period, the company sold medical supplies worth $3.54 billion, increasing the rate for the year by 1.2%. Pharmaceutical sales grew by 1.7% to $10.53 billion. At the same time, medical devices were sold in the amount of $6.49 billion, which is 6.9% less than in the same period last year.

The information and recommendations contained in this analytical document are published strictly for information purposes and are not considered as an offer to buy or sell the trading tools mentioned above and are not intended to motivate to perform certain transactions
Something went wrong